Shein Seeks $50 Billion Valuation Despite Profit Drop
MSM sells IPO momentum while X is unobserved; filed profits fell 38.7%, and a sought valuation is still not a market price.
Business
Johnson and Johnson Offers $5.5 Billion Talc Framework
Reuters says settlement; 95% acceptance, future-claim exclusion, uncapped value, releases and payment keep J&J's offer a conditional framework.
DCC Board Backs Takeover Despite Shareholder Opposition
Deal headlines call the sale agreed; the board has recommended an offer whose shareholder vote, conditions, approvals, and close remain ahead.
Cracker Barrel Names David Deno as Next CEO
X is unobserved; culture-war accounts call succession a logo verdict, while Guardian and Reuters lack the board record needed to prove causation.
Failed Wainua Trial Tempers AstraZeneca Revenue Growth
X is unobserved; Guardian celebrates pipeline speed, while Reuters keeps completed revenue growth separate from one failed clinical trial.
Liberty Expands London Fabric Floor by 140 Percent
X is unobserved; Guardian's sewing-boom frame has a larger floor and more staff, but expansion and sales growth do not establish profit.
Boston Scientific Plans $800 Million Restructuring
X is unobserved; Reuters compresses a four-year plan, while the SEC filing separates estimated costs, future cash and undelivered savings.
OpenAI Plans 250 Dublin Hires Over Two Years
X is unobserved; Reuters' workforce-tripling frame compresses two years into today, while the lease and staff count precede filled jobs and payroll.
Fairlife Restarts Four Plants After Cyberattack
Ransomware headlines chase a theft claim while the operating record stops at restart; X yielded no usable post, and full cyber recovery remains unproved.